GPT and liver disorder: Interestingly, ALT, AST, and ALP levels did not change significantly throughout the study, supporting recent findings that routine liver enzyme monitoring in all isotretinoin‐treated patients may not be necessary unless risk factors such as pre‐existing liver disease or concomitant hepatotoxic medications are present [16].